Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services is recalling Fluconazole 200 mg tablets because they may have been mislabeled as Valsartan or Fluconazole 100 mg.
Aidapak Services, LLC is recalling Acetaminophen chew tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Pioglitazone HCL 15 mg tablets because they may have been mislabeled as Doxycycline or Lovastatin.
Aidapak Services is recalling Exemestane 25 mg tablets because they may be mislabeled as Omega-3 Fatty Acid capsules.
Aidapak Services is recalling Lithium Carbonate ER tablets due to a labeling error where they may be mislabeled as other medications.
Aidapak Services, LLC is recalling Calcium Polycarbophil tablets that may be mislabeled as Caffeine tablets. The error involves a label mixup during repacking.
Aidapak Services, LLC is recalling Doxazosin Mesylate 1 mg tablets that may be mislabeled as Pyridoxine HCl 100 mg.
Aidapak Services, LLC is recalling 16,044 Docusate Sodium capsules because they may have been mislabeled as other medications. The affected drugs were distributed in four western states.
Aidapak Services, LLC is recalling CapsuleTOPRIL 6.25 mg tablets because they may have been mislabeled as Lubiprostone 24 mcg capsules.
Novartis is recalling Theraflu Daytime Severe Cold & Cough powder packets and NeoCitran products due to the potential presence of foreign substances.
Novartis Consumer Health is recalling NeoCitran Extra Strength powder packets because they may contain foreign substances. The products were distributed nationwide and internationally.
Aidapak Services is recalling Niacin TR 1000 mg tablets because they may have been mislabeled as 750 mg tablets. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Terazosin HCL 5 mg capsules due to a potential label mixup with Doxazosin Mesylate 1 mg tablets.
Aidapak Services, LLC is recalling Gabapentin 600 mg tablets because they may have been mislabeled as Aripiprazole 15 mg.
Novartis Consumer Health is recalling Theraflu MAX-D and NeoCitran powder packets because they may contain foreign substances.
Aidapak Services, LLC is recalling 5 mg hydrocortisone tablets because they may have been mislabeled as other prescription drugs.
Bard Access Systems is recalling Low Profile Ports with 6.6 Fr catheters because some silicone catheters may be undersized to 5.3 Fr.
Aidapak Services is recalling 1,000 mg sodium chloride tablets that may be mislabeled as repaglinide. The error involves specific lots distributed in four western states.
Aidapak Services is recalling Fluvastatin 20 mg capsules because they may have been mislabeled as a different medication.
Aidapak Services, LLC is recalling Isosorbide Dinitrate 10 mg tablets because they may have been mislabeled as Sodium Chloride or Calcitriol.
Aidapak Services is recalling Metoprolol Tartrate 25 mg tablets because they may have been mislabeled as Docusate Sodium 250 mg capsules.
Aidapak Services, LLC is recalling Atropine Sulfate/Diphenoxylate HCL tablets because they may have been mislabeled as Cyanocobalamin or Tri-Buffered Aspirin.
Aidapak Services, LLC is recalling specific lots of multivitamin chew tablets because they may have been mislabeled as other drugs.
Aidapak Services, LLC is recalling Niacin 500 mg tablets because they may have been mislabeled as Naproxen or Docusate Sodium.
Aidapak Services, LLC is recalling Desloratadine 5 mg tablets due to a potential label mixup with Ascorbic Acid 250 mg tablets.